BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 17681398)

  • 21. PIK3CA gene mutations and amplifications in uterine cancers, identified by methods that avoid confounding by PIK3CA pseudogene sequences.
    Miyake T; Yoshino K; Enomoto T; Takata T; Ugaki H; Kim A; Fujiwara K; Miyatake T; Fujita M; Kimura T
    Cancer Lett; 2008 Mar; 261(1):120-6. PubMed ID: 18180098
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of cyclin D1 splice variants is differentially associated with outcome in non-small cell lung cancer patients.
    Li R; An SJ; Chen ZH; Zhang GC; Zhu JQ; Nie Q; Xie Z; Guo AL; Mok TS; Wu YL
    Hum Pathol; 2008 Dec; 39(12):1792-801. PubMed ID: 18715616
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Absence of PIK3CA hotspot mutations in hepatocellular carcinoma in Japanese patients.
    Tanaka Y; Kanai F; Tada M; Asaoka Y; Guleng B; Jazag A; Ohta M; Ikenoue T; Tateishi K; Obi S; Kawabe T; Yokosuka O; Omata M
    Oncogene; 2006 May; 25(20):2950-2. PubMed ID: 16331247
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnostic assay based on hsa-miR-205 expression distinguishes squamous from nonsquamous non-small-cell lung carcinoma.
    Lebanony D; Benjamin H; Gilad S; Ezagouri M; Dov A; Ashkenazi K; Gefen N; Izraeli S; Rechavi G; Pass H; Nonaka D; Li J; Spector Y; Rosenfeld N; Chajut A; Cohen D; Aharonov R; Mansukhani M
    J Clin Oncol; 2009 Apr; 27(12):2030-7. PubMed ID: 19273703
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PIK3CA mutations as prognostic factor in squamous cell lung carcinoma.
    McGowan M; Hoven AS; Lund-Iversen M; Solberg S; Helland Å; Hirsch FR; Brustugun OT
    Lung Cancer; 2017 Jan; 103():52-57. PubMed ID: 28024696
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumor expression of S100A6 correlates with survival of patients with stage I non-small-cell lung cancer.
    De Petris L; Orre LM; Kanter L; Pernemalm M; Koyi H; Lewensohn R; Lehtiö J
    Lung Cancer; 2009 Mar; 63(3):410-7. PubMed ID: 18620780
    [TBL] [Abstract][Full Text] [Related]  

  • 27. No somatic genetic change in the paxillin gene in nonsmall-cell lung cancer.
    Pallier K; Houllier AM; Le Corre D; Cazes A; Laurent-Puig P; Blons H
    Mol Carcinog; 2009 Jul; 48(7):581-5. PubMed ID: 19353596
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Marital status and non-small cell lung cancer survival: the Lung Cancer Database Project in Japan.
    Saito-Nakaya K; Nakaya N; Akechi T; Inagaki M; Asai M; Goto K; Nagai K; Nishiwaki Y; Tsugane S; Fukudo S; Uchitomi Y
    Psychooncology; 2008 Sep; 17(9):869-76. PubMed ID: 18033697
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The prognostic effect of natural killer cell infiltration to tumoral tissues in stage I non-small cell lung cancer].
    Karadayi S; Kayi Cangir A; Ozturk S; Dizbay Sak S; Akal M; Akay H
    Tuberk Toraks; 2008; 56(3):251-6. PubMed ID: 18932025
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of smoking during radiotherapy, respiratory insufficiency, and hemoglobin levels on outcome in patients irradiated for non-small-cell lung cancer.
    Rades D; Setter C; Schild SE; Dunst J
    Int J Radiat Oncol Biol Phys; 2008 Jul; 71(4):1134-42. PubMed ID: 18258387
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Refining prognosis in non-small-cell lung cancer.
    Sun Z; Yang P
    N Engl J Med; 2007 Jan; 356(2):189-90; author reply 190-1. PubMed ID: 17215540
    [No Abstract]   [Full Text] [Related]  

  • 32. p53AIP1 expression can be a prognostic marker in non-small cell lung cancer.
    Yamashita SI; Masuda Y; Yoshida N; Matsuzaki H; Kurizaki T; Haga Y; Ikei S; Miyawaki M; Kawano Y; Chujyo M; Kawahara K
    Clin Oncol (R Coll Radiol); 2008 Mar; 20(2):148-51. PubMed ID: 17851056
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PIK3CA gene mutations in breast carcinoma in Malaysian patients.
    Ching-Shian Leong V; Jabal MF; Leong PP; Abdullah MA; Gul YA; Seow HF
    Cancer Genet Cytogenet; 2008 Dec; 187(2):74-9. PubMed ID: 19027487
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The influence of sex in non-small cell lung cancer.
    Wheatley-Price P; Blackhall F; Thatcher N
    Onkologie; 2009 Oct; 32(10):547-8. PubMed ID: 19816068
    [No Abstract]   [Full Text] [Related]  

  • 35. Five-gene signature in non-small-cell lung cancer.
    Gounaris I
    N Engl J Med; 2007 Apr; 356(15):1582; author reply 1583. PubMed ID: 17436431
    [No Abstract]   [Full Text] [Related]  

  • 36. Analysis of SOX4 gene mutation in non-small cell lung cancer tissues.
    Chen QL; Zheng WL; Yao WJ; Nie LW; Cheng SH; Ma WL
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Oct; 24(5):505-9. PubMed ID: 17922414
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fas-1377 A/G polymorphism in lung cancer.
    Gormus U; Ergen A; Yaylim-Eraltan I; Yilmaz H; Turna A; Bozkurt N; Isbir T
    In Vivo; 2007; 21(4):663-6. PubMed ID: 17708363
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic role of K-Ras mutations in non-small cell lung cancer: still an issue for open debate.
    Neri M; Cesario A; Granone P; Dominioni L; Puntoni R; D'Angelillo RM; Russo P
    Lung Cancer; 2006 Sep; 53(3):393-5; author reply 397-8. PubMed ID: 16887233
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gender difference in survival of resected non-small cell lung cancer: histology-related phenomenon?
    Chang JW; Asamura H; Kawachi R; Watanabe S
    J Thorac Cardiovasc Surg; 2009 Apr; 137(4):807-12. PubMed ID: 19327500
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetic alterations in the PI3K pathway in prostate cancer.
    Sun X; Huang J; Homma T; Kita D; Klocker H; Schafer G; Boyle P; Ohgaki H
    Anticancer Res; 2009 May; 29(5):1739-43. PubMed ID: 19443396
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.